These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 5170673)

  • 21. [Immunity and leukemia. II. Immunological pattern of lymphocytes in chronic lymphatic leukemia].
    Danieli G; Montroni M; Malini PL; Bagnara GP; Lauria F; Cremonini G; Tura S
    G Clin Med; 1971 Jun; 52(6):427-45. PubMed ID: 5142778
    [No Abstract]   [Full Text] [Related]  

  • 22. Receptor sites for complement on certain human peripheral blood lymphocytes.
    Michlmayr G; Huber H
    J Immunol; 1970 Sep; 105(3):670-6. PubMed ID: 4989556
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapy of chronic lymphatic leukemia].
    Theml H
    Verh Dtsch Ges Inn Med; 1973; 79():323-34. PubMed ID: 4790231
    [No Abstract]   [Full Text] [Related]  

  • 24. The use of complexes of lymphocyte antigens with antibody as immunogens for the preparation of antilymphocytic sera.
    Zola H; Thomas D; Mosedale B
    Experientia; 1972 Feb; 28(2):192-3. PubMed ID: 5020355
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies with heterologous antilymphocytic serum as a therapy for chronic lymphocytic leukemia.
    Tsirimbas AD; Pfisterer H; Hornung B; Thierfelder S; Michlmayr G; Stich W
    Blut; 1969 Oct; 19(7):420-3. PubMed ID: 5260739
    [No Abstract]   [Full Text] [Related]  

  • 26. [Potency determination of horse anti-human-lymphocyte serum (ALS) by means of the lymphocyte resistance test, a modification of Schroder's leukocyte resistance test].
    Mundt B; Preussner S; Frick G; Bast G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(4):462-9. PubMed ID: 54295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antibodies to DNA in the serum of patients with chronic lymphatic leukemia].
    Stefani NV
    Probl Gematol Pereliv Krovi; 1971; 16(4):31-3. PubMed ID: 5120490
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunotherapeutic effect of sensitized leukocytes and antiserum on mouse leukemia.
    Hill GJ; Atkins RC; Parks S; Littlejohn K; Eiseman B
    Surg Forum; 1969; 20():122-4. PubMed ID: 5383026
    [No Abstract]   [Full Text] [Related]  

  • 29. [PHA in vitro lymphocytic blastogenesis in children with acute leukemia].
    Bardare M; Accorsi A; Apollonio T; Careddu P
    Minerva Pediatr; 1969 Jun; 21(23):1019-24. PubMed ID: 5280394
    [No Abstract]   [Full Text] [Related]  

  • 30. Antigenic changes on the surface of lymphocytes from patients with chronic lymphocytic leukemia.
    Bentwich Z; Weiss DW; Sulitzeanu D; Kedar E; Izak G; Cohen I; Eyal O
    Cancer Res; 1972 Jul; 32(7):1375-83. PubMed ID: 5063974
    [No Abstract]   [Full Text] [Related]  

  • 31. Influence of immune suppression on the induction of neoplasms by MLV and MSV.
    Law LW
    Bibl Haematol; 1973; 39():662-70. PubMed ID: 4360189
    [No Abstract]   [Full Text] [Related]  

  • 32. [Rosette formation in healthy persons and in patients with chronic lymphatic leukemia].
    Fink U; Strebel J; Weig J; Sepp F; Rastetter J; Muller-Berat N
    Verh Dtsch Ges Inn Med; 1973; 79():543-5. PubMed ID: 4790289
    [No Abstract]   [Full Text] [Related]  

  • 33. [Electrophoretic characterization of lymphocytes from patients with chronic lymphatic leukemia].
    Schopow K; Walther F; Schubert JC
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1606-8. PubMed ID: 1030058
    [No Abstract]   [Full Text] [Related]  

  • 34. The production of antilymphocytic serum.
    Woiwod AJ
    Proc R Soc Med; 1970 Sep; 63(9):949-50. PubMed ID: 4991013
    [No Abstract]   [Full Text] [Related]  

  • 35. [Purification and characteristics of immunosuppressive equine antibodies against human lymphocytes].
    Tilz GP; Mathois H
    Wien Med Wochenschr; 1973 Dec; 123(49):732-6. PubMed ID: 4763133
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of calf thymus extract on surface structure and lysosomal apparatus in lymphocytes of patients with chronic lymphatic leukemia.
    Aleksandrowicz J; Blicharski J; Cichocki T; Dobrowolski J; Kwiatkowski A; Lisiewicz J; Sasiadek U; Skotnicki AB; Wazewska-Czyzewska M
    Haematologica; 1977 Jun; 62(3):267-78. PubMed ID: 408240
    [No Abstract]   [Full Text] [Related]  

  • 37. [Cellular specificity of heterologous, antilymphocyte serums of the rabbit].
    Thierfelder S; Möller ED; Kimura I; Dörmer P; Eulitz M
    Z Gesamte Exp Med Einschl Exp Chir; 1968 May; 147(1):44-59. PubMed ID: 5695267
    [No Abstract]   [Full Text] [Related]  

  • 38. [Fine structure of circulating lymphocytes under the effect of antilymphocyte serum (ALS) in chronic lymphatic leukemia].
    Hu D; Pfisterer H; Lani K
    Blut; 1970 May; 20(5):273-81. PubMed ID: 4986661
    [No Abstract]   [Full Text] [Related]  

  • 39. [Immunocytochemistry of chronic lymphatic leukemia. A critical revision (author's transl)].
    Tridente G
    Haematologica; 1979 Oct; 64 Suppl():89-92. PubMed ID: 120289
    [No Abstract]   [Full Text] [Related]  

  • 40. [Reactivity of leukemic leukocytes to heterologous and homologous anti-thymocytic and anti-lymphocytic antibodies of different origins].
    Goret P; Ducos J; Salmon H; Ohayon E; Pris J; Toma B
    Bull Acad Natl Med; 1971 Jun; 155(21):527-37. PubMed ID: 4941657
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.